Literature DB >> 15699461

Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction.

Jiang Xu1, Oscar A Carretero, Ying Sun, Edward G Shesely, Nour-Eddine Rhaleb, Yun-He Liu, Tang-Dong Liao, James J Yang, Michael Bader, Xiao-Ping Yang.   

Abstract

Kinins exert cardioprotective effects via 2 G-protein-coupled receptors, B1 and B2. Using B1 kinin receptor gene knockout mice (B1-/-), we tested the hypotheses that the B1 receptor plays an important role in preservation of cardiac function, whereas lack of B1 may accelerate cardiac remodeling and dysfunction after myocardial infarction, and that B2 receptors may compensate for lack of B1, whereas blockade of B2 receptors in B1-/- mice may cause further deterioration of cardiac function and remodeling. Female B1-/- mice and wild-type controls (C57BL/6J, B1+/+) underwent sham surgery or myocardial infarction and were treated with either vehicle or B2-antagonist (icatibant, 500 microg/kg per day, subcutaneous) for 8 weeks. We found that in sham myocardial infarction, B1-/- mice had a larger left ventricular diastolic chamber dimension both initially and at 4 to 8 weeks compared with B1+/+. Left ventricular mass and myocyte size were also larger in B1-/- with sham operation than in B1+/+, although cardiac function did not differ between strains. After myocardial infarction, cardiac remodeling and function were similar in both strains, although B1-/- mice tended to have lower blood pressure. Blockade of B2 receptors tended to worsen cardiac remodeling and dysfunction in B1-/- but not in B1+/+. These results may suggest that B2 receptors play an important role in compensating for lack of B1 receptors in mice with myocardial infarction. Dual blockade of both B1 and B2 eliminates this compensation, leading to further deterioration of cardiac dysfunction and remodeling after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699461      PMCID: PMC4593484          DOI: 10.1161/01.HYP.0000153322.04859.81

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  32 in total

1.  Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.

Authors:  X P Yang; Y H Liu; E G Shesely; M Bulagannawar; F Liu; O A Carretero
Journal:  Hypertension       Date:  1999-07       Impact factor: 10.190

2.  Role of kinins in the control of renal papillary blood flow, pressure natriuresis, and arterial pressure.

Authors:  J Tornel; M I Madrid; M García-Salom; K J Wirth; F J Fenoy
Journal:  Circ Res       Date:  2000-03-17       Impact factor: 17.367

Review 3.  Activation of bradykinin B1 receptor by ACE inhibitors.

Authors:  Tatjana Ignjatovic; Fulong Tan; Viktor Brovkovych; Randal A Skidgel; Ervin G Erdös
Journal:  Int Immunopharmacol       Date:  2002-12       Impact factor: 4.932

4.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

Authors:  Y H Liu; X P Yang; V G Sharov; O Nass; H N Sabbah; E Peterson; O A Carretero
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

5.  The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats.

Authors:  C Emanueli; J Chao; D Regoli; L Chao; A Ni; P Madeddu
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

6.  Bradykinin B(1) receptor-mediated changes in renal hemodynamics during endotoxin-induced inflammation.

Authors:  Joost P Schanstra; Maria E Marin-Castaño; Françoise Praddaude; Ivan Tack; Jean-Louis Ader; Jean-Pierre Girolami; Jean-Loup Bascands; Benoit Jeunier
Journal:  J Am Soc Nephrol       Date:  2000-07       Impact factor: 10.121

7.  Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor?

Authors:  Jean-Philippe Fortin; Fernand Gobeil; Albert Adam; Domenico Regoli; Francois Marceau
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-03-20       Impact factor: 4.733

8.  Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure.

Authors:  Jiang Xu; Oscar A Carretero; Yun-He Liu; Fang Yang; Edward G Shesely; Nancy Oja-Tebbe; Xiao-Ping Yang
Journal:  J Card Fail       Date:  2004-02       Impact factor: 5.712

9.  Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia.

Authors:  C Emanueli; A Minasi; A Zacheo; J Chao; L Chao; M B Salis; S Straino; M G Tozzi; R Smith; L Gaspa; G Bianchini; F Stillo; M C Capogrossi; P Madeddu
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

10.  Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle.

Authors:  C Emanueli; A Zacheo; A Minasi; J Chao; L Chao; M B Salis; T Stacca; S Straino; M C Capogrossi; P Madeddu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

View more
  20 in total

1.  Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice.

Authors:  Adam R Wende; Jamie Soto; Curtis D Olsen; Karla M P Pires; John C Schell; Frederic Larrieu-Lahargue; Sheldon E Litwin; Masao Kakoki; Nobuyuki Takahashi; Oliver Smithies; E Dale Abel
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

2.  Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.

Authors:  Ahmed A Elmarakby; Jan M Williams; John D Imig; Jennifer S Pollock; David M Pollock
Journal:  Vascul Pharmacol       Date:  2006-09-26       Impact factor: 5.773

3.  Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling.

Authors:  Hang Yin; Julie Chao; Michael Bader; Lee Chao
Journal:  Peptides       Date:  2007-05-25       Impact factor: 3.750

4.  Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.

Authors:  Masao Kakoki; Kelli A Sullivan; Carey Backus; John M Hayes; Sang Su Oh; Kunjie Hua; Adil M H Gasim; Hirofumi Tomita; Ruriko Grant; Sarah B Nossov; Hyung-Suk Kim; J Charles Jennette; Eva L Feldman; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 5.  Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.

Authors:  Ervin G Erdös; Fulong Tan; Randal A Skidgel
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

6.  Protective role of AT(2) and B(1) receptors in kinin B(2)-receptor-knockout mice with myocardial infarction.

Authors:  Jiang Xu; Oscar A Carretero; Liping Zhu; Edward G Shesely; Nour-Eddine Rhaleb; Xiangguo Dai; Luchen Wang; James J Yang; Xiao-Ping Yang
Journal:  Clin Sci (Lond)       Date:  2013-01       Impact factor: 6.124

7.  Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.

Authors:  Yu-Yu Yao; Hang Yin; Bo Shen; Lee Chao; Julie Chao
Journal:  J Card Fail       Date:  2007-09       Impact factor: 5.712

8.  Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice.

Authors:  Lei Xi; Anindita Das; Zhi-Qing Zhao; Vanessa F Merino; Michael Bader; Rakesh C Kukreja
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

9.  Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications.

Authors:  Jenny Pena Dias; Sébastien Talbot; Jacques Sénécal; Pierre Carayon; Réjean Couture
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

10.  Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.

Authors:  Dirk Westermann; Thomas Walther; Konstantinos Savvatis; Felcicitas Escher; Meike Sobirey; Alexander Riad; Michael Bader; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.